RecruitingNot ApplicableNCT07137234
Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy.
Efficacy of Botulinum Toxin Injection in Reducing Scar Following Cheilorrhaphy: A Randomized Controlled Clinical Trial.
Sponsor
Mansoura University
Enrollment
32 participants
Start Date
Mar 15, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
the aim of the study will be directed to evaluate clinically the effect of botulinum toxin type A injection on reducing the scar following cleft lip surgical repair.
Eligibility
Min Age: 10 Weeks
Inclusion Criteria3
- patients with mild to severe unilateral cleft lip requiring repair
- free from any systemic disease
- with or without cleft palate
Exclusion Criteria2
- patients with syndromic type of cleft lip
- patients with systemic disease
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREModified Millard rotation advancement flap technique
the cleft is repaired by surgical intervention
DRUGbotulinum toxin injection (BTX A) before surgical intervention
the patient will receive Botulinum toxin type A followed by surgical closure of cleft lip
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07137234